Uttam Yashwant Patil
Amministratore Delegato presso ABVC BIOPHARMA, INC.
Profilo
Uttam Yashwant Patil is currently the Chief Executive Officer at ABVC BioPharma, Inc. since 2023 and the Manager-Research & Development at Rgene Corp.
since 2022.
He holds a doctorate degree from National Tsing-Hua University and undergraduate and graduate degrees from the University of Pune.
Posizioni attive di Uttam Yashwant Patil
| Società | Posizione | Inizio |
|---|---|---|
| ABVC BIOPHARMA, INC. | Amministratore Delegato | 23/06/2023 |
Biokey, Inc.
 Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Direttore operativo | 01/05/2023 |
Rgene Corp.
 Rgene Corp. Financial ConglomeratesFinance Rgene Corp. operates as an investment holding American company. | Direttore Tecnico/Scientifico/R&S | 01/05/2023 |
Formazione di Uttam Yashwant Patil
| National Tsing-Hua University | Doctorate Degree |
| University of Pune | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABVC BIOPHARMA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Rgene Corp. operates as an investment holding American company. | Finance |
- Borsa valori
- Insiders
- Uttam Yashwant Patil
